At my last appointment the doctor (who was filling in while mine was on vacation) mentioned that we would be discussing at my next appointment whether I needed a glucose test or not. Supposedly, the doctors in the group I go to believe that it is an overprescribed test that not everyone needs. I was under the impression that it was a standard test that everyone got. Did anyone not/ or is not planning to take a glucose test? I'd just like a little more information before I have the discussion with my doctor at the next appointment.
BFP #1 - 03/13 Ectopic @ 5 weeks
BFP#2 - 09/13 Natural m/c @ 6 weeks
BFP #3 - 12/13 Natural m/c @ 6 weeks
BFP #4 - 04/14 EDD - 9/12/14
Re: No glucose test?
I did a typical postprandial (1-2 hour) test via glucometer with #3, and did the same over a course of a few days with #4. I ate what constitutes a normal meal for me as it provides a more accurate representation of how my body metabolizes glucose.
My midwife allows her clients to choose whether they want to test for impaired glucose tolerance (not the same as diabetes, nor is "GD"), and what method they wish to use, A1C or test at home.
ETA: I'll return with the current research and data after finishing this episode of House.
"Screening for 'Gestational Diabetes,'" the authors put gestational diabetes in quotation marks because there's no such thing as gestational diabetes. It is an invention of obstetricians that describes an elevated glucose level in the blood, a level that is normal in pregnancy and without complications.
REVIEWER'S CONCLUSIONS: There are insufficient data for any reliable conclusions about the effects of treatments for impaired glucose tolerance on perinatal outcome."
BFP#1: 2/2/13 ~ exact m/c date unknown but around 3/20 at 10 weeks ~ diagnosed with PMP ~ D&C on 4/5 ~ TTA for at least 1 year due to PMP ~ cleared to TTC 1/14
BFP#2: 2/7/14 ~ m/c 2/20/14 ~ possibly due to chemical pregnancy ~ TG no D&C is needed
Surprise BFP#3: 4/4/14 ~ super duper extra happy (and nervous) about this one - EDD 12/9/14!!!
John Joseph was born on 12/12/14 at 7 lbs. 11 oz. He is the most beautiful rainbow baby we could have wished for!
It just can't be healthy for me or the baby. Vom.
"Almost everywhere in the world, “gestational diabetes” is a frequent diagnosis. We should therefore not be surprised by the tendency to assign it the status of a disease. This might appear as a feat, since this diagnosis is not based on any specific symptom, but just on the effects of an intervention (giving glucose) on blood biochemistry.
One of the ways to transform a diagnosis into a disease is to list its complications. The well-documented fact that women carrying this label are more at risk than others to develop later on in life a non-insulin dependent diabetes has often been presented as a complication.(14) But this “type 2 diabetes” is not a consequence of reduced glucose tolerance in pregnancy. It is simply the expression, in another context, of a particular metabolic type. One might even claim that the only interest of glucose tolerance test in pregnancy is to identify a population at risk of developing a type 2 diabetes. But when a woman is looking forward to having a baby, is it the right time to bother her with glucose intake and blood samples, and to tell her that she is more at risk than others to have a future chronic disease? It is probably more important to talk routinely about nutrition and exercise.
Gestational hypertension has also been presented as a complication of gestational diabetes. In fact an isolated increased blood pressure in pregnancy is a transitory physiological reaction associated with good perinatal outcomes.(15, 16, 17, 18) Once more the concomitant expression of a particular metabolic type should not be confused with the evolution of a disease towards complications.
Professor Jarrett, a London epidemiologist, made a synthesis of the questions inspired by such associations. He stressed that women who carry this label are, on average, older and heavier than the overall population of pregnant women, and their average blood pressure is higher. This is enough to explain differences in perinatal outcomes. The results of glucose tolerance tests are superfluous. According to Professor Jarrett, gestational diabetes is a “non-entity”.(19)
The concept of fetal complications is also widespread. Fetal death has long been thought to be associated with gestational diabetes. However all well-designed studies looking at comparable groups of women dismissed this belief, in populations as divers as Western European (20) or Chinese (21), and also in Singapore (22) and Mauritius.(23) High birth weight has also been presented as a complication. In fact it should be considered an association whose expression is influenced by maternal age, parity and the degree of nutritional unbalance. If there is a cause and effect relation, it might be the other way round: a big baby requires more glucose than a small one. It is significant that in the case of twins “when the demand is double” the glucose tolerance test is more often positive than for singleton pregnancies. Only hypoglycemia of the newborn baby might be considered a complication, although there are multiple risk factors.
Another way to transform a diagnosis into a disease is to establish therapeutic guidelines. Until now, no study has ever demonstrated any positive effect of a pharmacological treatment on the maternal and neonatal morbidity rates, in a population with impaired glucose tolerance. On the contrary no pharmacological particular treatment is able to reduce the risks of neonatal hypoglycaemia.(24,25) However gestational diabetes is often treated with drugs. The frequency of pharmacological treatment has even been evaluated among the fellows of the American College of Obstetricians and Gynecologists (ACOG).(26) It appears that 96% of these practitioners routinely screen for gestational diabetes. When glycaemic control is not considered acceptable, 82% prescribe insulin right away, while 13% try first glyburide, an hypoglycaemic oral drug of the sulfonylureas family.
While practitioners are keen on drugs, there are more and more studies comparing the advantages of human insulin and synthetic insulins lispro and aspart,(27, 28) or comparing the effects of twice-daily regimen with four-times-daily regimen of short-acting and intermediate-actinginsulins.(29) Meanwhile the comparative advantages of several oral hypoglycaemic drugs are also evaluated. The criteria are always short- term and “glycaemic control” is the main objective.(30) The fact, for example, that sulfonylureas cross the placenta should lead to caution and to raise questions about the long-term future of children exposed to such drugs during crucial phases of their development."
Women who have a low risk for diabetes may not have the screening test. To be low-risk, all of these statements must be true:
BFP #2 5/7/13 EDD 1/14/2014 Ectopic discovered 5/21/13, lost left tube
Referred to RE, blood work done August 2013, AMH 0.27, all else normal, HSG clear
BFP #1 5/12/12; EDD 1/20/13; Eliana Grace born 1/25/13
BFP #2 12/11/13; EDD 8/23/14; M/C 6 weeks
BFP #3 4/3/14; EDD 12/13/14